We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 75,766

Dutch Health Care Inspectorate launches online questionnaire on pharmacovigilance
  • Allen & Overy LLP
  • Netherlands
  • May 26 2017

The Health Care Inspectorate (IGZ) has developed a risk model to gather information about the risks that may derive from the pharmacovigilance system


The Week in Weed: May 26, 2017
  • Seyfarth Shaw LLP
  • USA
  • May 26 2017

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. Vermont governor snuffs legal pot, tells


Whose lie is it anyway? Not for employer to decide if whistleblowing disclosure is protected
  • Squire Patton Boggs
  • United Kingdom
  • May 26 2017

For a whistleblower to benefit from the statutory protections, his disclosure must be protected, i.e., be (usually) about the breach of a legal


Continued Focus on Pricing in the Pharma Sector
  • CMS Cameron McKenna
  • European Union, United Kingdom
  • May 26 2017

Recent announcements by both the UK Competition & Markets Authority (CMA) and the European Commission in relation to investigations in the


New regulation applicable to the medical devices sector
  • Cuatrecasas Gonçalves Pereira
  • European Union
  • May 26 2017

The new regulation applicable to the medical devices sector entered into force today: European Parliament and Council Regulations 2017745 (for


The Ball’s In Your Court
  • Clyde & Co LLP
  • United Kingdom
  • May 25 2017

Defenders should seize the opportunity to seek assertive case management of complex negligence claims, following Lord Glennie’s comments in JD v


Trump Administration FY 2018 Budget and Healthcare Programs
  • Holland & Knight LLP
  • USA
  • May 25 2017

The Trump Administration released on May 23, 2017, its full Fiscal Year (FY) 2018 budget request, titled "A New Foundation for American Greatness."


The Last “Cabilly” Challenge Quietly Settles
  • Fish & Richardson PC
  • USA
  • May 25 2017

U.S. Pat. No. 6,331,415, commonly referred to as “Cabilly II,” has been called one of the most-litigated patents of all time, having been challenged


Japan Legal Update Vol.25
  • Jones Day
  • Japan
  • May 25 2017

On April 14, 2017, the House of Representatives passed a bill to partially amend the Civil Code ("Bill"). The Bill is under deliberation in the House


Due Diligence: Calculating the Regulatory Review Period for Patent Term Extension
  • Pepper Hamilton LLP
  • USA
  • May 25 2017

When applying for a patent term extension (PTE), due diligence matters. If an applicant did not act with due diligence during the testing phase or